vs
Apple Hospitality REIT, Inc.（APLE）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Apple Hospitality REIT, Inc.的季度营收约是Orthofix Medical Inc.的1.5倍（$326.4M vs $219.9M），Apple Hospitality REIT, Inc.净利率更高（9.1% vs -1.0%，领先10.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -2.0%），Apple Hospitality REIT, Inc.自由现金流更多（$282.0M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -0.5%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
APLE vs OFIX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $219.9M |
| 净利润 | $29.6M | $-2.2M |
| 毛利率 | 37.2% | 71.1% |
| 营业利润率 | 15.2% | 0.2% |
| 净利率 | 9.1% | -1.0% |
| 营收同比 | -2.0% | 2.0% |
| 净利润同比 | -0.7% | 92.4% |
| 每股收益（稀释后） | $0.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $326.4M | $219.9M | ||
| Q3 25 | $373.9M | $205.6M | ||
| Q2 25 | $384.4M | $203.1M | ||
| Q1 25 | $327.7M | $193.6M | ||
| Q4 24 | $333.0M | $215.7M | ||
| Q3 24 | $378.8M | $196.6M | ||
| Q2 24 | $390.1M | $198.6M | ||
| Q1 24 | $329.5M | $188.6M |
| Q4 25 | $29.6M | $-2.2M | ||
| Q3 25 | $50.9M | $-22.8M | ||
| Q2 25 | $63.6M | $-14.1M | ||
| Q1 25 | $31.2M | $-53.1M | ||
| Q4 24 | $29.8M | $-29.1M | ||
| Q3 24 | $56.3M | $-27.4M | ||
| Q2 24 | $73.9M | $-33.4M | ||
| Q1 24 | $54.0M | $-36.0M |
| Q4 25 | 37.2% | 71.1% | ||
| Q3 25 | 40.6% | 72.2% | ||
| Q2 25 | 42.6% | 68.7% | ||
| Q1 25 | 39.0% | 62.8% | ||
| Q4 24 | 38.6% | 69.0% | ||
| Q3 24 | 41.9% | 68.7% | ||
| Q2 24 | 44.6% | 67.8% | ||
| Q1 24 | 40.1% | 67.5% |
| Q4 25 | 15.2% | 0.2% | ||
| Q3 25 | 19.4% | -8.3% | ||
| Q2 25 | 22.1% | -7.9% | ||
| Q1 25 | 15.5% | -25.2% | ||
| Q4 24 | 15.0% | -5.3% | ||
| Q3 24 | 20.5% | -9.6% | ||
| Q2 24 | 24.0% | -12.5% | ||
| Q1 24 | 21.7% | -15.6% |
| Q4 25 | 9.1% | -1.0% | ||
| Q3 25 | 13.6% | -11.1% | ||
| Q2 25 | 16.6% | -6.9% | ||
| Q1 25 | 9.5% | -27.4% | ||
| Q4 24 | 9.0% | -13.5% | ||
| Q3 24 | 14.9% | -13.9% | ||
| Q2 24 | 19.0% | -16.8% | ||
| Q1 24 | 16.4% | -19.1% |
| Q4 25 | $0.13 | $-0.05 | ||
| Q3 25 | $0.21 | $-0.57 | ||
| Q2 25 | $0.27 | $-0.36 | ||
| Q1 25 | $0.13 | $-1.35 | ||
| Q4 24 | $0.13 | $-0.76 | ||
| Q3 24 | $0.23 | $-0.71 | ||
| Q2 24 | $0.31 | $-0.88 | ||
| Q1 24 | $0.22 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $82.0M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $3.1B | $450.0M |
| 总资产 | $4.9B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.49× | — |
8季度趋势，按日历期对齐
| Q4 25 | $8.5M | $82.0M | ||
| Q3 25 | $50.3M | $62.9M | ||
| Q2 25 | $7.9M | $65.6M | ||
| Q1 25 | $14.9M | $58.0M | ||
| Q4 24 | $10.3M | $83.2M | ||
| Q3 24 | $6.1M | $30.1M | ||
| Q2 24 | $7.2M | $26.4M | ||
| Q1 24 | $4.9M | $27.0M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $157.2M | ||
| Q2 25 | $1.5B | $157.0M | ||
| Q1 25 | $1.5B | $156.9M | ||
| Q4 24 | $1.5B | $157.0M | ||
| Q3 24 | $1.5B | $118.5M | ||
| Q2 24 | $1.5B | $118.0M | ||
| Q1 24 | $1.5B | $118.2M |
| Q4 25 | $3.1B | $450.0M | ||
| Q3 25 | $3.2B | $442.5M | ||
| Q2 25 | $3.2B | $458.3M | ||
| Q1 25 | $3.2B | $458.3M | ||
| Q4 24 | $3.3B | $503.1M | ||
| Q3 24 | $3.3B | $525.9M | ||
| Q2 24 | $3.3B | $546.0M | ||
| Q1 24 | $3.3B | $570.3M |
| Q4 25 | $4.9B | $850.6M | ||
| Q3 25 | $4.9B | $832.6M | ||
| Q2 25 | $4.9B | $837.2M | ||
| Q1 25 | $4.9B | $823.1M | ||
| Q4 24 | $5.0B | $893.3M | ||
| Q3 24 | $5.0B | $867.9M | ||
| Q2 24 | $5.1B | $882.0M | ||
| Q1 24 | $5.0B | $906.0M |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | 0.36× | ||
| Q2 25 | 0.48× | 0.34× | ||
| Q1 25 | 0.48× | 0.34× | ||
| Q4 24 | 0.45× | 0.31× | ||
| Q3 24 | 0.46× | 0.23× | ||
| Q2 24 | 0.46× | 0.22× | ||
| Q1 24 | 0.45× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $282.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 86.4% | 7.6% |
| 资本支出强度资本支出/营收 | 27.0% | 4.9% |
| 现金转化率经营现金流/净利润 | 12.50× | — |
| 过去12个月自由现金流最近4个季度 | $516.8M | $-1.3M |
8季度趋势，按日历期对齐
| Q4 25 | $370.2M | $27.7M | ||
| Q3 25 | $126.4M | $12.4M | ||
| Q2 25 | $108.8M | $11.6M | ||
| Q1 25 | $49.1M | $-18.4M | ||
| Q4 24 | $405.4M | $23.7M | ||
| Q3 24 | $128.2M | $11.7M | ||
| Q2 24 | $127.3M | $9.0M | ||
| Q1 24 | $54.7M | $-18.6M |
| Q4 25 | $282.0M | $16.8M | ||
| Q3 25 | $109.0M | $2.5M | ||
| Q2 25 | $96.2M | $4.5M | ||
| Q1 25 | $29.5M | $-25.1M | ||
| Q4 24 | $327.1M | $15.2M | ||
| Q3 24 | $113.1M | $6.3M | ||
| Q2 24 | $115.0M | $-360.0K | ||
| Q1 24 | $34.4M | $-29.1M |
| Q4 25 | 86.4% | 7.6% | ||
| Q3 25 | 29.2% | 1.2% | ||
| Q2 25 | 25.0% | 2.2% | ||
| Q1 25 | 9.0% | -13.0% | ||
| Q4 24 | 98.2% | 7.0% | ||
| Q3 24 | 29.9% | 3.2% | ||
| Q2 24 | 29.5% | -0.2% | ||
| Q1 24 | 10.4% | -15.4% |
| Q4 25 | 27.0% | 4.9% | ||
| Q3 25 | 4.7% | 4.8% | ||
| Q2 25 | 3.3% | 3.5% | ||
| Q1 25 | 6.0% | 3.5% | ||
| Q4 24 | 23.5% | 4.0% | ||
| Q3 24 | 4.0% | 2.7% | ||
| Q2 24 | 3.2% | 4.7% | ||
| Q1 24 | 6.2% | 5.6% |
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 1.01× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Occupancy | $293.0M | 90% |
| Hotel Other | $17.2M | 5% |
| Food And Beverage | $16.3M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
